Search Results1-17 of  17

  • OMAE Kenji ID: 9000240538271

    Department of Urology, Tokyo Women's Medical University (2012 from CiNii)

    Articles in CiNii:1

    • Similar functional outcomes after partial nephrectomy for clinical T1b and T1a renal cell carcinoma (2012)
  • OMAE Kenji ID: 9000258520138

    Department of Urology, Kidney Center, Tokyo Women's Medical University (2013 from CiNii)

    Articles in CiNii:1

    • A case of retroperitoneal ganglioneuroma removed by laparoscopic surgery (2013)
  • OMAE Kenji ID: 9000365044357

    Articles in CiNii:1

    • The magnitude of best tumor shrinkage during second-line targeted therapy affects progression-free survival but not overall survival in patients with metastatic renal cell carcinoma (2016)
  • OMAE Kenji ID: 9000366130333

    Articles in CiNii:1

    • Late recurrence of a malignant hypoglycemia‑inducing pelvic solitary fibrous tumor secreting high‑molecular‑weight insulin‑like growth factor‑II: A case report with protein analysis (2016)
  • OMAE Kenji ID: 9000369738804

    Articles in CiNii:1

    • Sarcopenia and the Modified Glasgow Prognostic Score are Significant Predictors of Survival Among Patients with Metastatic Renal Cell Carcinoma Who are Receiving First-Line Sunitinib Treatment. (2016)
  • OMAE Kenji ID: 9000403270214

    Articles in CiNii:1

    • Efficacy and safety of third-line molecular-targeted therapy in metastatic renal cell carcinoma resistant to first-line vascular endothelial growth factor receptor tyrosine kinase inhibitor and second-line therapy (2018)
  • OMAE Kenji ID: 9000403569211

    Articles in CiNii:1

    • Evaluation of renal function change during first-line tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma (2017)
  • OMAE Kenji ID: 9000403569368

    Articles in CiNii:1

    • Sarcopenia predicts survival outcomes among patients with urothelial carcinoma of the upper urinary tract undergoing radical nephroureterectomy: a retrospective multi-institution study (2017)
  • OMAE Kenji ID: 9000403569385

    Articles in CiNii:1

    • Effect of the timing of best tumor shrinkage on survival of patients with metastatic renal cell carcinoma who received first-line tyrosine kinase inhibitor therapy (2017)
  • OMAE Kenji ID: 9000403569393

    Articles in CiNii:1

    • Evaluation of tumor burden after sequential molecular-targeted therapy in patients with metastatic renal cell carcinoma (2017)
  • OMAE Kenji ID: 9000403569401

    Articles in CiNii:1

    • Effect of Systemic Inflammation on Survival in Patients With Metastatic Renal Cell Carcinoma Receiving Second-line Molecular-targeted Therapy (2017)
  • OMAE Kenji ID: 9000403737807

    Articles in CiNii:1

    • Evaluation of Preoperative Aspartate Transaminase/Alanine Transaminase Ratio as an Independent Predictive Biomarker in Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy: A Propensity Score Matching Study (2017)
  • OMAE Kenji ID: 9000403737814

    Articles in CiNii:1

    • Preoperative controlling nutritional status (CONUT) score as a novel predictive biomarker of survival in patients with localized urothelial carcinoma of the upper urinary tract treated with radical nephroureterectomy (2017)
  • OMAE Kenji ID: 9000403737821

    Articles in CiNii:1

    • Time to progression after first-line tyrosine kinase inhibitor predicts survival in patients with metastatic renal cell carcinoma receiving second-line molecular-targeted therapy (2017)
  • OMAE Kenji ID: 9000403777666

    Articles in CiNii:1

    • Decreased relative dose intensity during the early phase of treatment impacts the therapeutic efficacy of sunitinib in metastatic renal cell carcinoma (2018)
  • Omae Kenji ID: 9000345265338

    Department of Urology, Tokyo Women' s Medical University (2015 from CiNii)

    Articles in CiNii:1

    • A CASE OF SOLITARY ADRENAL TUMOR METASTASIZED FROM RECTAL CANCER (2015)
  • Omae Kenji ID: 9000345338323

    東京女子医科大学泌尿器科 (2017 from CiNii)

    Articles in CiNii:1

    • 4. 透析患者の転移性腎癌に対するVEGFR-TKI治療抵抗後逐次的mTOR阻害薬治療の経験 (2017)
Page Top